TP53 and melanoma: Activation of p53 after treatment with tunicamycin, thapsigargin or brefeldin A, was also reported in primary human trabecular meshwork cells, Mel-RM and MM200 melanoma, and in breast MCF-7 and cervical HeLa cancer cell lines [48,49,50].